Owkin launches K Navigator to accelerate discovery in biomedical research
Owkin announced the unveiling of K Navigator, an AI-powered research co-pilot designed to support scientists across key phases of biomedical R&D.
K Navigator is an agentic playground where researchers can explore, refine, and validate hypotheses, accelerating the quality and pace of their discoveries. With K Navigator, Owkin moves closer to its vision of developing the world’s first Biological Artificial Superintelligence (BASI).
Hubert Chaperon, Chief Growth Officer at Owkin, joined FH24 presenting the talk “MOSAIC: Building the world’s largest spatial multiomics dataset in oncology”, as part of the Thematic Track From Campus to Bedside and Beyond: Strategies for Tomorrow’s Biomedical Breakthroughs. The talk, included in the session: Practical Applications of BioInnovation in Translational Medicine, explored how Owkin and its consortium partners are enabling precision medicine with spatial biology and AI.
Date: May 6th, 2025 | Source: Digital Health Global
Join us and our global community of health innovators in Berlin on November 11-12, 2025.